FLT1

WikiDoc Resources for FLT1
Articles
Most recent articles on FLT1 Most cited articles on FLT1 Review articles on FLT1 Articles on FLT1 in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on FLT1 Images of FLT1 Photos of FLT1 Podcasts & MP3s on FLT1 Videos on FLT1
Evidence Based Medicine
Cochrane Collaboration on FLT1 Bandolier on FLT1 TRIP on FLT1
Clinical Trials
Ongoing Trials on FLT1 at Clinical Trials.gov Trial results on FLT1 Clinical Trials on FLT1 at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on FLT1 NICE Guidance on FLT1 NHS PRODIGY Guidance FDA on FLT1 CDC on FLT1
Books
Books on FLT1
News
FLT1 in the news Be alerted to news on FLT1 News trends on FLT1
Commentary
Blogs on FLT1
Definitions
Definitions of FLT1
Patient Resources / Community
Patient resources on FLT1 Discussion groups on FLT1 Patient Handouts on FLT1 Directions to Hospitals Treating FLT1 Risk calculators and risk factors for FLT1
Healthcare Provider Resources
Symptoms of FLT1 Causes & Risk Factors for FLT1 Diagnostic studies for FLT1 Treatment of FLT1
Continuing Medical Education (CME)
CME Programs on FLT1
International
FLT1 en Espanol FLT1 en Francais
Business
FLT1 in the Marketplace Patents on FLT1
Experimental / Informatics
List of terms related to FLT1

Fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor), also known as FLT1, is a human gene.

Oncogene FLT belongs to the src gene family and is related to oncogene ROS (MIM 165020). Like other members of this family, it shows tyrosine protein kinase activity that is important for the control of cell proliferation and differentiation. The sequence structure of the FLT gene resembles that of the FMS gene (MIM 164770); hence, Yoshida et al. (1987) proposed the name FLT as an acronym for FMS-like tyrosine kinase.[supplied by OMIM]

See also

• VEGF receptors

Further reading

• Petrova TV, Makinen T, Alitalo K (1999). "Signaling via vascular endothelial growth factor receptors". Exp. Cell Res. 253 (1): 117–30. doi:10.1006/excr.1999.4707. PMID 10579917.CS1 maint: Multiple names: authors list (link)
• Sato Y, Kanno S, Oda N; et al. (2000). "Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction". Ann. N. Y. Acad. Sci. 902: 201–5, discussion 205–7. PMID 10865839.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• Boyd AW, Lackmann M (2002). "Signals from Eph and ephrin proteins: a developmental tool kit". Sci. STKE. 2001 (112): RE20. doi:10.1126/stke.2001.112.re20. PMID 11741094.
• Luttun A, Tjwa M, Carmeliet P (2003). "Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders". Ann. N. Y. Acad. Sci. 979: 80–93. PMID 12543719.CS1 maint: Multiple names: authors list (link)
• Maynard SE, Venkatesha S, Thadhani R, Karumanchi SA (2005). "Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia". Pediatr. Res. 57 (5 Pt 2): 1R–7R. doi:10.1203/01.PDR.0000159567.85157.B7. PMID 15817508.CS1 maint: Multiple names: authors list (link)
• Shibuya M (2007). "Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis". Angiogenesis. 9 (4): 225–30, discussion 231. doi:10.1007/s10456-006-9055-8. PMID 17109193.
• Widmer M, Villar J, Benigni A; et al. (2007). "Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review". Obstetrics and gynecology. 109 (1): 168–80. doi:10.1097/01.AOG.0000249609.04831.7c. PMID 17197602.CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link)
• López-Novoa JM (2007). "Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia". Nephrol. Dial. Transplant. 22 (3): 712–4. doi:10.1093/ndt/gfl768. PMID 17210583.